Comprehensive Eye Exams

A rare case of tubulointerstitial nephritis and uveitis syndrome in a teenager highlights the importance of multidisciplinary diagnosis and management.

Ocular salvage and preservation of vision are essentially dependent on early diagnosis, and several studies have been conducted to identify the factors leading to delayed diagnosis at presentation.

The EyeSouth affiliate network now includes more than 320 doctors providing medical and surgical eye care services at over 235 locations.

Santen introduces low-dose atropine in Germany, marking a significant advancement in myopia management for children amid a global epidemic.

Survey participants cited cost concerns, perceived inevitability, and deprioritization as obstacles to receiving eye care.

New research reveals collagen mimetic peptides may effectively restore ocular tissue stiffness, offering hope for myopia and other eye diseases.

These screening solutions will work to make early detection of diabetic retinopathy easier with on-the-spot screening.

Explaining how different examinations are billed by insurance to patients can make a difference in patient care.

Embracing new technology is good for patients and provides protection against malpractice claims.

Maggie Cline, MPH, initially joined the organization in 2022 and served as Executive Director Utah.

The report highlights clinical successes, innovation, research, and patient outcomes.

Bryce St Clair, OD, MPH, authors the June edition of the Cultural Responsiveness Blog, and urges doctors to consider cultural and socioeconomic backgrounds when caring for patients.

An official approval by the FDA in the United States can boost adoption rate of atropine and antimyopia glasses, which will change the landscape of myopia management.

The qVPT, a suprathreshold test comprised of 15 trials at 9 cycles per degree and 20% contrast, measures the patient’s response time to visual stimuli and the number of correct responses.

In this Q&A, John D. Gelles, OD, and Steven Greenstein, MD, chat about what inspired them to launch the symposium, what makes this year’s agenda especially exciting, and why the future of refractive care depends on stronger collaboration between ODs and MDs.

The Early Detection of Vision Impairments for Children Act (EDVI), or HR 2527, would allow the federal government to award grants and cooperative agreements to eligible states and communities for children's vision care initiatives.

Insurance coverage from the second largest health plan in the US paves the way for expanded access to Luminopia’s unique amblyopia therapeutic.

Investigators reported that the benefits of the training for patients with hemianopia, driven by improved blind-side scanning, lasted for more than a month.

While the study included a range of patients in a variety of stages of presbyopia, the change in crystalline lens and anterior segment geometry was most pronounced in emmetropic and myopic presbyopes.

In honor of the Myopia Management Navigator’s 1-year anniversary, Dr Tucker shares clinical insights, practical tips, and business opportunities for optometrists looking to expand their scope and elevate patient care through evidence-based myopia management.

Arkansas Optometric Association legislative cochairs Matt Jones, OD; Matt Burns; and Joe Sugg, OD, discuss their involvement in their bill and provide context for its relevance.

According to a press release, Myatro XL is the first 0.05% atropine eye drop for pediatric myopia control. It will be commercially available in India in July 2025.

The report outlines views and behaviors of US adults regarding vision correction, managed vision care, eye examinations, prescription eyewear, reading glasses, and nonprescription sunglasses.

How studies into myopia management can increase access to vision care.

The survey results included 11,412 patients in the general population and 964 health care providers.

The supplemental BLA seeks approval for Eylea HD for both the treatment of macular edema following retinal vein occlusion and for broadening the dosing schedule to include every-4-week dosing across approved indications.

Following a discussion on low-dose atropine, Paul Karpecki, OD, FAAO, shares his views on what the future of myopia management looks like.